HHS Opens a Review of How Federal Vaccine Recommendations Are Classified

HHS has opened a public inquiry into the labels that sit beneath federal vaccine recommendations: routine, risk-based, and shared clinical decision-making. The August 24 request for information does not change a single recommendation today, but it puts the architecture behind future recommendations—evidence, access, clinical judgment, and public trust—squarely on the table.

### What It Is

The HHS Office of the Secretary has published a notice and request for information, tied to the Task Force on Safer Childhood Vaccines and the administration’s August 10 executive order on childhood vaccine recommendations. The docket is HHS-OS-2026-0332 (RIN 0991-ZA62), and comments are due September 20.

For the uninitiated, the categories are more than filing-cabinet labels. A routine recommendation generally makes vaccination the default for an age group; a risk-based recommendation turns on specified risk factors; and a shared-clinical-decision-making recommendation calls for an individualized discussion between clinician and patient or parent. HHS says the latter has also been called individual-based decision-making.

### What’s Changing

For now, the answer is: nothing operational. HHS expressly says this RFI is not a rule, proposed rule, or recommendation, and it does not alter existing recommendations, coverage requirements, or program obligations. An RFI is not a policy change; it is the government choosing which questions might shape the next policy move.

Those questions are unusually broad. HHS asks whether the current categories are clear and adequate, whether new or modified categories should be added, and how evidence quality, individual autonomy, religious freedom, and communication should figure in recommendation-making. It also asks commenters how any new framework could preserve vaccine access and predictable treatment under coverage rules, program eligibility, injury-compensation programs, and state law. The notice specifically solicits views on provider training, decision aids, documentation standards, and clearer coverage communication.

### Why It Matters

For clinicians and health systems, the significance is in the plumbing behind the clinical encounter. The category attached to a vaccine recommendation can shape how providers explain it, how patients understand it, how electronic tools display it, and whether people mistakenly assume a shared-decision recommendation means the vaccine is not covered. HHS itself cites evidence that clinicians report added time and confusion in implementing these recommendations; the agency is now inviting comments on whether the framework is helping or hindering.

That makes this more than a semantic debate with a very long name tag. The eventual question is whether a revised vocabulary can better signal evidentiary certainty and room for individualized judgment without creating new uncertainty about access, coverage, or clinical workflow. HHS has not answered that question. It has, however, formally asked it—and people who live with the answer in exam rooms and health-plan systems have until September 20 to put their evidence on the record.

Read the HHS request for information in the Federal Register (https://www.federalregister.gov/documents/2026/08/24/2026-17250/request-for-information-categories-used-in-federal-vaccine-recommendations-and-the-role-of-shared)